{"title":"Immune biomarkers for predicting postoperative pneumonia following hip fracture surgery.","authors":"Zemin Wu, Bing Li, Wenke Zhu, JingJing Shang, Jiapei Yao, Yong Huang, Jiansong Yin, Xindie Zhou","doi":"10.1080/17520363.2025.2491302","DOIUrl":"https://doi.org/10.1080/17520363.2025.2491302","url":null,"abstract":"<p><strong>Objective: </strong>Abnormalities of lymphocyte subsets have been observed in patients with pneumonia. This study investigated the diagnostic efficiency of lymphocyte subsets in the detection of early-stage postoperative pneumonia (POP) among older patients undergoing hip fracture surgery.</p><p><strong>Methods: </strong>A total of 576 patients with hip fracture were recruited and analyzed for lymphocyte subsets on the first postoperative day.</p><p><strong>Results: </strong>The incidence of POP was 10.6% (61/576) from March 2016 to December 2023. The area under the curve for the percentage of CD8+ HLA-DR+ T cells was higher than that of CD4+ T and CD4+ CD45RA+ T cells. A high percentage of CD8+ HLA-DR+ T cells was significantly associated with an increased occurrence of POP. The positive findings remained significant after adjusting for confounding factors. Among the multiple complications, patients with diabetes tended to have higher percentages of CD8+ HLA-DR+ T cells.</p><p><strong>Conclusions: </strong>The percentage of CD8+ HLA-DR+ T cells had a good predictive value for detecting early-stage POP. Multi-center prospective studies with larger sample sizes are needed to verify this finding.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 9","pages":"341-348"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143962944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-04-01DOI: 10.1080/17520363.2025.2485014
Gizem Tuğçe Alp, İbrahim Vasi, Emre Alp, Aslıhan Avanoğlu Güler, Hazan Karadeniz, Özlem Gülbahar, Abdulsamet Erden, Abdurrahman Tufan, Mehmet Akif Öztürk, Berna Göker, Şeminur Haznedaroğlu, Hamit Küçük
{"title":"PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.","authors":"Gizem Tuğçe Alp, İbrahim Vasi, Emre Alp, Aslıhan Avanoğlu Güler, Hazan Karadeniz, Özlem Gülbahar, Abdulsamet Erden, Abdurrahman Tufan, Mehmet Akif Öztürk, Berna Göker, Şeminur Haznedaroğlu, Hamit Küçük","doi":"10.1080/17520363.2025.2485014","DOIUrl":"10.1080/17520363.2025.2485014","url":null,"abstract":"<p><strong>Aim: </strong>Lungs are among the most affected organs in systemic sclerosis (SSc), with interstitial lung disease (ILD) being a leading cause of mortality. Biomarkers are increasingly explored for predicting SSc-ILD detection and progression. This study evaluates the roles of Krebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), and peroxiredoxin-4 (PRDX-4) in diagnosing SSc-ILD and monitoring progression.</p><p><strong>Methods: </strong>A total of 89 individuals (61 SSc patients and 28 healthy volunteers) were included. SSc patients were grouped based on pulmonary function tests and high-resolution computed tomography findings to determine SSc-ILD presence. Patients with SSc-ILD were further categorized by progressive pulmonary fibrosis (PPF) presence based on 2022 guidelines. Serum KL-6, SP-D, and PRDX-4 levels were measured using the Enzyme-Linked Immuno-Sorbent Assay method.</p><p><strong>Results: </strong>Of the 61 SSc patients, 34 (55.7%) had ILD. Serum KL-6 and PRDX-4 levels were significantly higher in SSc-ILD patients (<i>p</i> = 0.004 and <i>p</i> = 0.012, respectively). KL-6, SP-D, and PRDX-4 levels were elevated in the PPF group compared to stable disease (<i>p</i> = 0.001). PRDX-4 showed the highest diagnostic performance for PPF (AUC: 0.936, sensitivity: 85.7%, specificity: 85%).</p><p><strong>Conclusion: </strong>KL-6 is a well-established biomarker for SSc-ILD, but PRDX-4 offers superior diagnostic accuracy, especially in identifying PPF.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"349-355"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-04-17DOI: 10.1080/17520363.2025.2494498
Bülent Özlek, Süleyman Barutçu, Veysel Ozan Tanık
{"title":"Pericarditis and inflammatory biomarkers.","authors":"Bülent Özlek, Süleyman Barutçu, Veysel Ozan Tanık","doi":"10.1080/17520363.2025.2494498","DOIUrl":"10.1080/17520363.2025.2494498","url":null,"abstract":"","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 10","pages":"357-358"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143965586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of the effectiveness of C-reactive protein/albumin ratio on thrombus in patients undergoing transesophageal echo.","authors":"Erkan Kahraman, Koray Kalenderoglu, Kivanc Keskin, Gunseli Miray Ozdemir, Melih Oz, Lale Dinc Asarcikli","doi":"10.1080/17520363.2025.2496134","DOIUrl":"10.1080/17520363.2025.2496134","url":null,"abstract":"<p><strong>Background: </strong>Left atrial appendage thrombus (LAAT) is the predominant etiology of ischemic stroke in patients with atrial fibrillation (AF), and LAAT is optimally demonstrated by transesophageal echocardiography (TEE). The study aimed to assess patients with nonvalvular atrial fibrillation (NVAF) identified with thrombus using TEE compared to those without thrombus, utilizing the C-reactive protein/albumin ratio (CAR) as a sensitive biomarker.</p><p><strong>Methods: </strong>This study was conducted retrospectively at a single center with 668 patients with NVAF who underwent TEE. Patients were divided into two groups based on the presence or absence of LAAT on TEE. The levels of CAR, C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) were compared.</p><p><strong>Results: </strong>CAR was identified as an independent variable in patients with thrombus detected on TEE. (OR: 12.773, CI: 6.669-24.464, <i>p</i> < 0.001) Albumin was shown to have the highest area under the curve (AUC) value for thrombus prediction, followed by CAR, CRP, NLR, and PLR, in that order. (AUC: 0.999 CI: 0.993-1.000; 0.977 (0.962-0.987); 0.931 (0.909-0.949); 0.600 (0.562-0.937) <i>p</i> < 0.001, AUC: 0.574 CI: 0.535-0.612 p: 0.014).</p><p><strong>Conclusion: </strong>Our study demonstrates that CAR serves as an independent predictor of LAAT and shows more dependability than other biomarkers such as NLR, CRP, and PLR.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 10","pages":"385-392"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-04-24DOI: 10.1080/17520363.2025.2496128
Ale Eba, Syed Tasleem Raza, Irshad Ahmad Wani, Bashir Ahmad, Mohammad Abbas, Zeba Siddiqi, Sanchita Srivastava, Farzana Mahdi
{"title":"Association of APOB (rs515135) and PCSK9 (rs505151) gene polymorphisms with CAD in the Indian population.","authors":"Ale Eba, Syed Tasleem Raza, Irshad Ahmad Wani, Bashir Ahmad, Mohammad Abbas, Zeba Siddiqi, Sanchita Srivastava, Farzana Mahdi","doi":"10.1080/17520363.2025.2496128","DOIUrl":"10.1080/17520363.2025.2496128","url":null,"abstract":"<p><strong>Introduction: </strong>Coronary artery disease (CAD) is a multifactorial disorder influenced by both genetic and clinical risk factors. Lipid metabolism genes such as apolipoprotein B(APOB) (rs515135) and proprotein convertase subtilisin/kexin type 9 (PCSK9)(rs505151), have been associated with susceptibility to CAD. Study investigates the potential role of these genetic polymorphisms with risk of CAD in the Indian population.</p><p><strong>Materials and methods: </strong>A case-control study including 150 CAD cases and 150 controls. Angiographically proven Cases were recruited from the Cardiology Unit, Department of Medicine, Era's Lucknow Medical College. Genotyping was done using specific primers and restriction digestion; statistical analysis included t-tests, odds ratios, and haplotype analysis.</p><p><strong>Results: </strong>CAD cases(mean age 49.93 ± 9.13 years) had higher serum cholesterol and VLDL but lower systolic and diastolic BP compared to controls (mean age 56.47 ± 9.39 years). The APOB G allele showed a significant protective effect against CAD (OR: 0.431,<i>p</i> = 0.001).</p><p><strong>Conclusion: </strong>The APOB G allele may serve as a protective factor against CAD, highlighting its potential role in genetic screening for lower disease risk. Further large-scale studies are required to confirm these findings.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 10","pages":"371-377"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-03-30DOI: 10.1080/17520363.2025.2483157
Abdullah Yildirim, Omer Genc, Mert Evlice, Aslan Erdogan, Emre Pacaci, Ahmet Ozderya, Murat Gokhan Yerlikaya, Emre Sezici, Yeliz Guler, Omer Sen, Ahmet Guler, Ali Riza Akyuz, Levent Korkmaz, Ibrahim Halil Kurt
{"title":"Predictive power of ALBI score-based nomogram for 30-day mortality following transcatheter aortic valve implantation.","authors":"Abdullah Yildirim, Omer Genc, Mert Evlice, Aslan Erdogan, Emre Pacaci, Ahmet Ozderya, Murat Gokhan Yerlikaya, Emre Sezici, Yeliz Guler, Omer Sen, Ahmet Guler, Ali Riza Akyuz, Levent Korkmaz, Ibrahim Halil Kurt","doi":"10.1080/17520363.2025.2483157","DOIUrl":"10.1080/17520363.2025.2483157","url":null,"abstract":"<p><strong>Aim: </strong>This retrospective, multi-center study evaluates the relationships between novel liver function scoring systems - Albumin-Bilirubin (ALBI) score, EZ-ALBI, PALBI, and MELD-XI - and outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Feature importance was assessed with SHAP-values via the XGBoost-algorithm.</p><p><strong>Results: </strong>The ALBI score exhibited the strongest association with 30-day mortality after TAVI (AUC = 0.723, <i>p</i> < 0.001), outperforming other scores in this regard and consistently demonstrating predictive power across various subgroup populations. Higher 30-day mortality rates were observed in the higher tertiles of the ALBI score compared to the lower tertiles (log-rank p-value = 0.004). The ALBI-based nomogram (C-index = 0.81, 95% CI:0.73-0.86, <i>p</i> = 0 < 001) demonstrated superior predictive power for 30-day mortality post-TAVI compared to the STS (C-index = 0.71, 95% CI :0.64-0.77, <i>p</i> = 0 < 001). In addition, the nomogram showed a significant improvement in reclassification (69.3%, <i>p</i> < 0.001) and a stronger discrimination 15.2%, <i>p</i> < 0.001) compared to the STS. It integrates nine variables, first ALBI score (SHAP:1.165), including NYHA class (0.594), body mass index (0.510), glomerular filtration rate, creatinine, hemoglobin, gender, predilatation requirement, presence of chronic kidney disease, and providing a comprehensive risk assessment tool.</p><p><strong>Conclusion: </strong>This study exhibits the significance of liver dysfunction with AS patients and suggests incorporating liver function parameters in pre-operative risk assessments for better clinical outcomes in TAVI procedures.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"305-316"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-03-26DOI: 10.1080/17520363.2025.2483156
Nadire Aishan, Siwei Ju, Zhongqiu Zheng, Yongxia Chen, Qingna Meng, Qina He, Jiahang Zhang, Jiaheng Lang, Bojian Xie, Lidan Jin, Jun Shen, Yi Lu, Yangjun Cai, Feiyang Ji, Feilin Cao, Linbo Wang
{"title":"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.","authors":"Nadire Aishan, Siwei Ju, Zhongqiu Zheng, Yongxia Chen, Qingna Meng, Qina He, Jiahang Zhang, Jiaheng Lang, Bojian Xie, Lidan Jin, Jun Shen, Yi Lu, Yangjun Cai, Feiyang Ji, Feilin Cao, Linbo Wang","doi":"10.1080/17520363.2025.2483156","DOIUrl":"10.1080/17520363.2025.2483156","url":null,"abstract":"<p><strong>Aims: </strong>Breast cancer is one of the most prevalent cancers among women, and early diagnosis is crucial in reducing the mortality rate. This study aims to identify novel, reliable, and specific biomarkers for breast cancer diagnosis using 5-Hydroxymethylcytosine (5hmC) signatures in circulating cell-free DNA (cfDNA).</p><p><strong>Materials and methods: </strong>We utilized the sensitive 5hmC seal method to map 5hmC profiles in cfDNA samples from 203 breast cancer patients and 60 healthy individuals. Machine learning models were applied to identify 5hmC marker signatures with high sensitivity and specificity.</p><p><strong>Results: </strong>A global loss of 5hmC was observed in the blood samples from cancer patients compared to the control group. Several specific 5hmC marker signatures were identified, providing a basis for distinguishing between tumor and healthy individuals.</p><p><strong>Conclusions: </strong>Our study offers a comprehensive understanding of genome-wide 5hmC in cfDNA from breast cancer patients, and identifies valuable epigenetic biomarkers for the minimally invasive diagnosis of breast cancer.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"317-328"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143708677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-05-01Epub Date: 2025-05-12DOI: 10.1080/17520363.2025.2496132
Juan Liu, Jun Yan, Juan Lv
{"title":"PCR targeting 16S rRNA, <i>cfb</i>, and <i>hylB</i> for group B Streptococcus detection in women with 35 to 37 weeks of pregnancy.","authors":"Juan Liu, Jun Yan, Juan Lv","doi":"10.1080/17520363.2025.2496132","DOIUrl":"10.1080/17520363.2025.2496132","url":null,"abstract":"<p><strong>Aims: </strong>Polymerase chain reaction (PCR) is a rapid molecular technique for pathogen detection, but its application in detecting group B Streptococcus (GBS) requires further exploration. This study assessed the diagnostic performance of the PCR method for GBS detection in pregnant women with 35 to 37 weeks of pregnancy.</p><p><strong>Methods: </strong>This study enrolled 116 women at 35-37 weeks of pregnancy and simultaneously collected two vaginal swab samples for GBS detection via culture and PCR methods.</p><p><strong>Results: </strong>Through the culture method, 21 (18.1%) samples were positive for GBS. Moreover, 24 (20.7%), 23 (19.8%), and 23 (19.8%) samples were positive for GBS according to PCR methods targeting 16S rRNA, cfb, and hylB, respectively. The results of PCR-based GBS detection of 16S rRNA (Kappa value = 0.917, <i>p</i> < 0.01), cfb (Kappa value = 0.944, <i>p</i> < 0.01), and hylB (Kappa value = 0.944, <i>p</i> < 0.01) were consistent with those of the culture method. The sensitivity and specificity were 1.000 and 0.968 for the PCR method targeting 16S rRNA, 1.000 and 0.979 for cfb, and 1.000 and 0.979 for hylB, respectively.</p><p><strong>Conclusion: </strong>PCR targeting 16S rRNA, <i>cfb</i>, and <i>hylB</i> may serve as a reliable diagnostic method for GBS detection in women with 35 to 37 weeks of pregnancy.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 10","pages":"379-384"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143980699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomarkers in medicinePub Date : 2025-04-01Epub Date: 2025-03-01DOI: 10.1080/17520363.2025.2473875
Ashok Kumar Pannu
{"title":"Enhancing risk stratification post-myocardial infarction: prognostic value of NT-proBNP and fQRS.","authors":"Ashok Kumar Pannu","doi":"10.1080/17520363.2025.2473875","DOIUrl":"10.1080/17520363.2025.2473875","url":null,"abstract":"","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 7","pages":"239-241"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preoperative blood neutrophil-to-lymphocyte ratio, hematocrit and fibrinogen predict prognosis in colorectal cancer.","authors":"Bing Luo, Kai Zhang, Ze-Kun Jiang, Ying-Kang Xie, Yi-Xiang Wu, Rong-Chang Wang, Jiong-Qiang Huang, Jing-Song Chen","doi":"10.1080/17520363.2025.2473310","DOIUrl":"10.1080/17520363.2025.2473310","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the prognostic potential of preoperative blood neutrophil to lymphocyte ratio (NLR), hematocrit (HCT) and Fibrinogen (FIB) level in patients with colorectal cancer (CRC).</p><p><strong>Methods: </strong>The data of 268 patients with CRC who underwent radical surgery from March 2013 to August 2017 in the First Affiliated Hospital of Guangzhou Medical University (Guangzhou, China) were retrospectively collected. The correlations between preoperative blood NLR, HCT and FIB level and the clinicopathologic features and prognosis were explored by Cox regression in the patients with CRC.</p><p><strong>Results: </strong>Univariate and multivariate analyses identified preoperative blood with high NLR (HR = 2.265, 95% CI: 1.437-3.570), low HCT (HR = 1.575, 95% CI: 1.010-2.454), and high FIB (HR = 1.667, 95% CI: 1.067-2.605) as independent predictors of reduced 5-year overall survival (OS). Furthermore, the patients were stratified into high (with 3 predictors), middle (with 2 predictors) and low (with 0 or 1 predictors) risk groups according to the number of the 3 independent prognostic predictors. The more independent predictors a patient has, the poorer their prognosis tends to be.</p><p><strong>Conclusions: </strong>Preoperative NLR, HCT, and FIB serve as cost-effective prognostic biomarkers in CRC. Their combination enables precise risk stratification, guiding personalized postoperative management.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"251-258"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12054928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143555841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}